Astera Labs, Inc.
ALAB
$71.20
-$0.44-0.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 144.33% | 179.32% | 206.23% | 619.03% | 269.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 144.33% | 179.32% | 206.23% | 619.03% | 269.44% |
| Cost of Revenue | 171.62% | 218.98% | 185.72% | 655.71% | 9.94% |
| Gross Profit | 136.36% | 167.64% | 212.67% | 609.25% | 1,086.47% |
| SG&A Expenses | -45.49% | 361.60% | 387.67% | 438.48% | 909.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.05% | 239.69% | 213.54% | 257.57% | 305.09% |
| Operating Income | 113.60% | -98.40% | -349.97% | -38.23% | -338.35% |
| Income Before Tax | 127.01% | 0.07% | 896.84% | 12.30% | -363.98% |
| Income Tax Expenses | -180.29% | -285.87% | 234.69% | -265.66% | 10,129.27% |
| Earnings from Continuing Operations | 134.22% | 72.52% | -143.05% | 62.28% | -432.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 134.22% | 72.52% | -143.05% | 62.28% | -432.80% |
| EBIT | 113.60% | -98.40% | -349.97% | -38.23% | -338.35% |
| EBITDA | 115.07% | -88.31% | -436.82% | -37.33% | -343.47% |
| EPS Basic | 111.02% | -58.30% | 41.97% | 91.12% | -263.36% |
| Normalized Basic EPS | 108.70% | -75.84% | 290.48% | 79.34% | -216.47% |
| EPS Diluted | 110.17% | -62.45% | 41.97% | 91.12% | -263.36% |
| Normalized Diluted EPS | 107.96% | -78.21% | 290.48% | 79.34% | -216.47% |
| Average Basic Shares Outstanding | 210.66% | 313.77% | 318.55% | 324.42% | 46.63% |
| Average Diluted Shares Outstanding | 239.06% | 359.49% | 318.55% | 324.42% | 46.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |